Pros and cons of 5-HT3 receptor antagonists in neuropsychiatric diseases. 2019

Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
Department of Psychiatry and Neuroscience, Faculty of Medicine, CERVO Brain Research Centre, Laval University, Quebec, Quebec, G1J 2G3, Canada. Electronic address: Rahimian78@gmail.com.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D012702 Serotonin Antagonists Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. 5-HT Antagonist,5-HT Antagonists,5-Hydroxytryptamine Antagonist,5-Hydroxytryptamine Antagonists,Antiserotonergic Agent,Antiserotonergic Agents,Serotonin Antagonist,Serotonin Blockader,Serotonin Blockaders,Serotonin Receptor Antagonist,Serotonin Receptor Blocker,Antagonists, 5-HT,Antagonists, 5-Hydroxytryptamine,Antagonists, Serotonin,Serotonin Receptor Antagonists,Serotonin Receptor Blockers,5 HT Antagonist,5 HT Antagonists,5 Hydroxytryptamine Antagonist,5 Hydroxytryptamine Antagonists,Agent, Antiserotonergic,Agents, Antiserotonergic,Antagonist, 5-HT,Antagonist, 5-Hydroxytryptamine,Antagonist, Serotonin,Antagonist, Serotonin Receptor,Antagonists, 5 HT,Antagonists, 5 Hydroxytryptamine,Antagonists, Serotonin Receptor,Blockader, Serotonin,Blockaders, Serotonin,Blocker, Serotonin Receptor,Blockers, Serotonin Receptor,Receptor Antagonist, Serotonin,Receptor Antagonists, Serotonin,Receptor Blocker, Serotonin,Receptor Blockers, Serotonin

Related Publications

Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
February 2003, Zeitschrift fur Rheumatologie,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
January 1991, Drug design and delivery,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
January 2017, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
December 1991, Pharmacological reviews,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
January 1991, Therapie,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
March 1997, Medicinal research reviews,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
January 2006, Current topics in medicinal chemistry,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
January 1991, Journal of neurology,
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
August 1997, European journal of cancer (Oxford, England : 1990),
Reza Rahimian, and Gohar Fakhfouri, and Mohammad Reza Zirak
January 2019, Beilstein journal of organic chemistry,
Copied contents to your clipboard!